nodes	percent_of_prediction	percent_of_DWPC	metapath
Adinazolam—GABRR1—forebrain—attention deficit hyperactivity disorder	0.0102	0.0312	CbGeAlD
Adinazolam—GABRD—forebrain—attention deficit hyperactivity disorder	0.00889	0.0271	CbGeAlD
Adinazolam—GABRG1—forebrain—attention deficit hyperactivity disorder	0.00856	0.0261	CbGeAlD
Adinazolam—GABRA5—forebrain—attention deficit hyperactivity disorder	0.00826	0.0252	CbGeAlD
Adinazolam—GABRA4—forebrain—attention deficit hyperactivity disorder	0.00749	0.0229	CbGeAlD
Adinazolam—GABRR3—nervous system—attention deficit hyperactivity disorder	0.00666	0.0203	CbGeAlD
Adinazolam—GABRB2—forebrain—attention deficit hyperactivity disorder	0.00627	0.0191	CbGeAlD
Adinazolam—GABRG2—forebrain—attention deficit hyperactivity disorder	0.00627	0.0191	CbGeAlD
Adinazolam—GABRD—midbrain—attention deficit hyperactivity disorder	0.00587	0.0179	CbGeAlD
Adinazolam—GABRG3—nervous system—attention deficit hyperactivity disorder	0.00583	0.0178	CbGeAlD
Adinazolam—GABRR2—nervous system—attention deficit hyperactivity disorder	0.00577	0.0176	CbGeAlD
Adinazolam—GABRA2—forebrain—attention deficit hyperactivity disorder	0.00573	0.0175	CbGeAlD
Adinazolam—GABRG1—midbrain—attention deficit hyperactivity disorder	0.00565	0.0172	CbGeAlD
Adinazolam—GABRG3—central nervous system—attention deficit hyperactivity disorder	0.00561	0.0171	CbGeAlD
Adinazolam—GABRR1—nervous system—attention deficit hyperactivity disorder	0.00556	0.0169	CbGeAlD
Adinazolam—GABRA1—forebrain—attention deficit hyperactivity disorder	0.00553	0.0169	CbGeAlD
Adinazolam—GABRB1—midbrain—attention deficit hyperactivity disorder	0.00548	0.0167	CbGeAlD
Adinazolam—GABRR2—cerebellum—attention deficit hyperactivity disorder	0.00543	0.0166	CbGeAlD
Adinazolam—GABRR1—central nervous system—attention deficit hyperactivity disorder	0.00535	0.0163	CbGeAlD
Adinazolam—GABRD—nervous system—attention deficit hyperactivity disorder	0.00483	0.0147	CbGeAlD
Adinazolam—GABRB3—forebrain—attention deficit hyperactivity disorder	0.00481	0.0147	CbGeAlD
Adinazolam—GABRD—central nervous system—attention deficit hyperactivity disorder	0.00465	0.0142	CbGeAlD
Adinazolam—GABRG1—nervous system—attention deficit hyperactivity disorder	0.00465	0.0142	CbGeAlD
Adinazolam—GABRA6—nervous system—attention deficit hyperactivity disorder	0.00462	0.0141	CbGeAlD
Adinazolam—GABRD—cerebellum—attention deficit hyperactivity disorder	0.00454	0.0139	CbGeAlD
Adinazolam—GABRB1—nervous system—attention deficit hyperactivity disorder	0.00451	0.0137	CbGeAlD
Adinazolam—GABRA5—nervous system—attention deficit hyperactivity disorder	0.00448	0.0137	CbGeAlD
Adinazolam—GABRG1—central nervous system—attention deficit hyperactivity disorder	0.00447	0.0136	CbGeAlD
Adinazolam—GABRG3—brain—attention deficit hyperactivity disorder	0.00446	0.0136	CbGeAlD
Adinazolam—GABRA6—central nervous system—attention deficit hyperactivity disorder	0.00445	0.0136	CbGeAlD
Adinazolam—GABRG1—cerebellum—attention deficit hyperactivity disorder	0.00437	0.0133	CbGeAlD
Adinazolam—GABRA6—cerebellum—attention deficit hyperactivity disorder	0.00435	0.0133	CbGeAlD
Adinazolam—GABRB1—central nervous system—attention deficit hyperactivity disorder	0.00434	0.0132	CbGeAlD
Adinazolam—GABRA5—central nervous system—attention deficit hyperactivity disorder	0.00432	0.0132	CbGeAlD
Adinazolam—GABRR1—brain—attention deficit hyperactivity disorder	0.00425	0.013	CbGeAlD
Adinazolam—GABRB1—cerebellum—attention deficit hyperactivity disorder	0.00424	0.0129	CbGeAlD
Adinazolam—GABRA3—nervous system—attention deficit hyperactivity disorder	0.00417	0.0127	CbGeAlD
Adinazolam—GABRB2—midbrain—attention deficit hyperactivity disorder	0.00414	0.0126	CbGeAlD
Adinazolam—GABRG2—midbrain—attention deficit hyperactivity disorder	0.00414	0.0126	CbGeAlD
Adinazolam—GABRA4—nervous system—attention deficit hyperactivity disorder	0.00407	0.0124	CbGeAlD
Adinazolam—GABRA3—central nervous system—attention deficit hyperactivity disorder	0.00402	0.0123	CbGeAlD
Adinazolam—GABRA4—central nervous system—attention deficit hyperactivity disorder	0.00392	0.0119	CbGeAlD
Adinazolam—GABRA4—cerebellum—attention deficit hyperactivity disorder	0.00383	0.0117	CbGeAlD
Adinazolam—GABRD—brain—attention deficit hyperactivity disorder	0.00369	0.0113	CbGeAlD
Adinazolam—GABRA1—midbrain—attention deficit hyperactivity disorder	0.00365	0.0111	CbGeAlD
Adinazolam—GABRG1—brain—attention deficit hyperactivity disorder	0.00355	0.0108	CbGeAlD
Adinazolam—GABRA6—brain—attention deficit hyperactivity disorder	0.00353	0.0108	CbGeAlD
Adinazolam—GABRB1—brain—attention deficit hyperactivity disorder	0.00344	0.0105	CbGeAlD
Adinazolam—GABRA5—brain—attention deficit hyperactivity disorder	0.00343	0.0105	CbGeAlD
Adinazolam—GABRB2—nervous system—attention deficit hyperactivity disorder	0.0034	0.0104	CbGeAlD
Adinazolam—GABRG2—nervous system—attention deficit hyperactivity disorder	0.0034	0.0104	CbGeAlD
Adinazolam—Halazepam—GABRQ—attention deficit hyperactivity disorder	0.00337	0.0991	CrCbGaD
Adinazolam—Nitrazepam—GABRQ—attention deficit hyperactivity disorder	0.00335	0.0984	CrCbGaD
Adinazolam—GABRB2—central nervous system—attention deficit hyperactivity disorder	0.00328	0.00999	CbGeAlD
Adinazolam—GABRG2—central nervous system—attention deficit hyperactivity disorder	0.00328	0.00999	CbGeAlD
Adinazolam—GABRG2—cerebellum—attention deficit hyperactivity disorder	0.0032	0.00977	CbGeAlD
Adinazolam—GABRB2—cerebellum—attention deficit hyperactivity disorder	0.0032	0.00977	CbGeAlD
Adinazolam—GABRA3—brain—attention deficit hyperactivity disorder	0.00319	0.00973	CbGeAlD
Adinazolam—GABRB3—midbrain—attention deficit hyperactivity disorder	0.00318	0.00969	CbGeAlD
Adinazolam—GABRA4—brain—attention deficit hyperactivity disorder	0.00311	0.00948	CbGeAlD
Adinazolam—GABRA2—nervous system—attention deficit hyperactivity disorder	0.00311	0.00948	CbGeAlD
Adinazolam—GABRE—nervous system—attention deficit hyperactivity disorder	0.00308	0.0094	CbGeAlD
Adinazolam—GABRA1—nervous system—attention deficit hyperactivity disorder	0.003	0.00916	CbGeAlD
Adinazolam—GABRA2—central nervous system—attention deficit hyperactivity disorder	0.00299	0.00913	CbGeAlD
Adinazolam—Flurazepam—GABRQ—attention deficit hyperactivity disorder	0.00298	0.0875	CrCbGaD
Adinazolam—Triazolam—GABRQ—attention deficit hyperactivity disorder	0.00297	0.0874	CrCbGaD
Adinazolam—GABRE—central nervous system—attention deficit hyperactivity disorder	0.00297	0.00905	CbGeAlD
Adinazolam—GABRA2—cerebellum—attention deficit hyperactivity disorder	0.00292	0.00892	CbGeAlD
Adinazolam—GABRA1—central nervous system—attention deficit hyperactivity disorder	0.00289	0.00882	CbGeAlD
Adinazolam—Oxazepam—GABRQ—attention deficit hyperactivity disorder	0.00288	0.0847	CrCbGaD
Adinazolam—Temazepam—GABRQ—attention deficit hyperactivity disorder	0.00285	0.0836	CrCbGaD
Adinazolam—GABRA1—cerebellum—attention deficit hyperactivity disorder	0.00283	0.00862	CbGeAlD
Adinazolam—Midazolam—GABRQ—attention deficit hyperactivity disorder	0.00276	0.0811	CrCbGaD
Adinazolam—GABRB3—nervous system—attention deficit hyperactivity disorder	0.00261	0.00797	CbGeAlD
Adinazolam—GABRG2—brain—attention deficit hyperactivity disorder	0.0026	0.00793	CbGeAlD
Adinazolam—GABRB2—brain—attention deficit hyperactivity disorder	0.0026	0.00793	CbGeAlD
Adinazolam—GABRB3—central nervous system—attention deficit hyperactivity disorder	0.00252	0.00767	CbGeAlD
Adinazolam—GABRB3—cerebellum—attention deficit hyperactivity disorder	0.00246	0.0075	CbGeAlD
Adinazolam—GABRA2—brain—attention deficit hyperactivity disorder	0.00238	0.00725	CbGeAlD
Adinazolam—Diazepam—GABRQ—attention deficit hyperactivity disorder	0.00236	0.0695	CrCbGaD
Adinazolam—GABRE—brain—attention deficit hyperactivity disorder	0.00236	0.00719	CbGeAlD
Adinazolam—GABRA1—brain—attention deficit hyperactivity disorder	0.0023	0.007	CbGeAlD
Adinazolam—GABRB3—brain—attention deficit hyperactivity disorder	0.002	0.00609	CbGeAlD
Adinazolam—Chlorpromazine—DRD5—attention deficit hyperactivity disorder	0.00155	0.0457	CrCbGaD
Adinazolam—CYP3A4—nervous system—attention deficit hyperactivity disorder	0.00134	0.00408	CbGeAlD
Adinazolam—CYP3A4—central nervous system—attention deficit hyperactivity disorder	0.00129	0.00393	CbGeAlD
Adinazolam—GABRR2—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.00123	0.00193	CbGpPWpGaD
Adinazolam—GABRA3—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.00122	0.00192	CbGpPWpGaD
Adinazolam—GABRA2—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.0012	0.00188	CbGpPWpGaD
Adinazolam—GABRB3—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.00119	0.00187	CbGpPWpGaD
Adinazolam—GABRG2—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.00117	0.00184	CbGpPWpGaD
Adinazolam—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—attention deficit hyperactivity disorder	0.00116	0.00182	CbGpPWpGaD
Adinazolam—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—attention deficit hyperactivity disorder	0.00115	0.0018	CbGpPWpGaD
Adinazolam—GABRR1—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.00111	0.00174	CbGpPWpGaD
Adinazolam—GABRR1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00109	0.00171	CbGpPWpGaD
Adinazolam—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—attention deficit hyperactivity disorder	0.00108	0.0017	CbGpPWpGaD
Adinazolam—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—attention deficit hyperactivity disorder	0.00107	0.00168	CbGpPWpGaD
Adinazolam—GABRR2—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.00106	0.00166	CbGpPWpGaD
Adinazolam—GABRR1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00104	0.00163	CbGpPWpGaD
Adinazolam—GABRR2—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00104	0.00163	CbGpPWpGaD
Adinazolam—GABRR1—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.00103	0.00162	CbGpPWpGaD
Adinazolam—GABRA1—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.00102	0.0016	CbGpPWpGaD
Adinazolam—GABRG3—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.00102	0.00159	CbGpPWpGaD
Adinazolam—GABRB1—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.001	0.00157	CbGpPWpGaD
Adinazolam—Chlorprothixene—DRD3—attention deficit hyperactivity disorder	0.000995	0.0292	CrCbGaD
Adinazolam—GABRR2—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000994	0.00156	CbGpPWpGaD
Adinazolam—GABRR1—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000992	0.00155	CbGpPWpGaD
Adinazolam—CYP2C19—Melatonin metabolism and effects—MAOA—attention deficit hyperactivity disorder	0.000991	0.00155	CbGpPWpGaD
Adinazolam—GABRR2—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000987	0.00155	CbGpPWpGaD
Adinazolam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—attention deficit hyperactivity disorder	0.000979	0.00153	CbGpPWpGaD
Adinazolam—Chlorprothixene—DRD1—attention deficit hyperactivity disorder	0.000976	0.0287	CrCbGaD
Adinazolam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—attention deficit hyperactivity disorder	0.000951	0.00149	CbGpPWpGaD
Adinazolam—GABRA6—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.000948	0.00149	CbGpPWpGaD
Adinazolam—GABRR2—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000946	0.00148	CbGpPWpGaD
Adinazolam—GABRA4—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.000936	0.00147	CbGpPWpGaD
Adinazolam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—attention deficit hyperactivity disorder	0.000934	0.00146	CbGpPWpGaD
Adinazolam—GABRR1—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000922	0.00145	CbGpPWpGaD
Adinazolam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—attention deficit hyperactivity disorder	0.000918	0.00144	CbGpPWpGaD
Adinazolam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—attention deficit hyperactivity disorder	0.000912	0.00143	CbGpPWpGaD
Adinazolam—Clomipramine—ADRA2A—attention deficit hyperactivity disorder	0.000911	0.0268	CrCbGaD
Adinazolam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—attention deficit hyperactivity disorder	0.000895	0.0014	CbGpPWpGaD
Adinazolam—GABRR2—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.00088	0.00138	CbGpPWpGaD
Adinazolam—CYP3A4—Estrogen metabolism—COMT—attention deficit hyperactivity disorder	0.000879	0.00138	CbGpPWpGaD
Adinazolam—GABRG3—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.000874	0.00137	CbGpPWpGaD
Adinazolam—GABRB1—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.000861	0.00135	CbGpPWpGaD
Adinazolam—GABRG3—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000858	0.00134	CbGpPWpGaD
Adinazolam—GABRB2—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.000856	0.00134	CbGpPWpGaD
Adinazolam—GABRR1—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000853	0.00134	CbGpPWpGaD
Adinazolam—GABRB1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000845	0.00132	CbGpPWpGaD
Adinazolam—GABRA1—SIDS Susceptibility Pathways—TPH2—attention deficit hyperactivity disorder	0.000835	0.00131	CbGpPWpGaD
Adinazolam—GABRA5—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.000831	0.0013	CbGpPWpGaD
Adinazolam—GABRG3—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000818	0.00128	CbGpPWpGaD
Adinazolam—GABRA3—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.000816	0.00128	CbGpPWpGaD
Adinazolam—GABRA6—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.000815	0.00128	CbGpPWpGaD
Adinazolam—GABRR2—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000814	0.00127	CbGpPWpGaD
Adinazolam—GABRG3—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000813	0.00127	CbGpPWpGaD
Adinazolam—GABRB1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000806	0.00126	CbGpPWpGaD
Adinazolam—GABRA4—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.000805	0.00126	CbGpPWpGaD
Adinazolam—GABRA2—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.000802	0.00126	CbGpPWpGaD
Adinazolam—GABRB1—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000801	0.00125	CbGpPWpGaD
Adinazolam—GABRA6—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000799	0.00125	CbGpPWpGaD
Adinazolam—GABRB3—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.000797	0.00125	CbGpPWpGaD
Adinazolam—Chlorpromazine—DRD4—attention deficit hyperactivity disorder	0.000795	0.0234	CrCbGaD
Adinazolam—GABRR1—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000793	0.00124	CbGpPWpGaD
Adinazolam—GABRA4—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000789	0.00124	CbGpPWpGaD
Adinazolam—GABRR1—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000784	0.00123	CbGpPWpGaD
Adinazolam—GABRG2—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.000783	0.00123	CbGpPWpGaD
Adinazolam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—attention deficit hyperactivity disorder	0.000783	0.00123	CbGpPWpGaD
Adinazolam—GABRG3—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000779	0.00122	CbGpPWpGaD
Adinazolam—GABRR1—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000779	0.00122	CbGpPWpGaD
Adinazolam—GABRB1—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000767	0.0012	CbGpPWpGaD
Adinazolam—GABRA6—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000763	0.0012	CbGpPWpGaD
Adinazolam—GABRA6—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000758	0.00119	CbGpPWpGaD
Adinazolam—GABRR2—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000756	0.00119	CbGpPWpGaD
Adinazolam—GABRA4—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000753	0.00118	CbGpPWpGaD
Adinazolam—GABRR2—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000748	0.00117	CbGpPWpGaD
Adinazolam—GABRA4—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000748	0.00117	CbGpPWpGaD
Adinazolam—GABRR2—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000743	0.00116	CbGpPWpGaD
Adinazolam—GABRB2—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.000736	0.00115	CbGpPWpGaD
Adinazolam—GABRA6—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000726	0.00114	CbGpPWpGaD
Adinazolam—GABRG3—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000725	0.00114	CbGpPWpGaD
Adinazolam—GABRB2—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000722	0.00113	CbGpPWpGaD
Adinazolam—GABRA1—SIDS Susceptibility Pathways—CHRNA4—attention deficit hyperactivity disorder	0.000718	0.00112	CbGpPWpGaD
Adinazolam—GABRA4—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000717	0.00112	CbGpPWpGaD
Adinazolam—GABRA5—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.000715	0.00112	CbGpPWpGaD
Adinazolam—GABRB1—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000714	0.00112	CbGpPWpGaD
Adinazolam—GABRR1—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000707	0.00111	CbGpPWpGaD
Adinazolam—GABRA3—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.000702	0.0011	CbGpPWpGaD
Adinazolam—GABRA5—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000701	0.0011	CbGpPWpGaD
Adinazolam—Clomipramine—SLC6A4—attention deficit hyperactivity disorder	0.000695	0.0204	CrCbGaD
Adinazolam—GABRA2—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.00069	0.00108	CbGpPWpGaD
Adinazolam—GABRB2—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000689	0.00108	CbGpPWpGaD
Adinazolam—GABRA3—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000689	0.00108	CbGpPWpGaD
Adinazolam—Chlorprothixene—DRD2—attention deficit hyperactivity disorder	0.000688	0.0202	CrCbGaD
Adinazolam—GABRB3—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.000685	0.00107	CbGpPWpGaD
Adinazolam—Chlorpromazine—DRD3—attention deficit hyperactivity disorder	0.000685	0.0201	CrCbGaD
Adinazolam—GABRA1—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.000684	0.00107	CbGpPWpGaD
Adinazolam—GABRB2—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000684	0.00107	CbGpPWpGaD
Adinazolam—GABRA2—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000677	0.00106	CbGpPWpGaD
Adinazolam—GABRA6—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000675	0.00106	CbGpPWpGaD
Adinazolam—GABRR2—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000674	0.00106	CbGpPWpGaD
Adinazolam—GABRG2—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.000673	0.00105	CbGpPWpGaD
Adinazolam—Chlorpromazine—DRD1—attention deficit hyperactivity disorder	0.000673	0.0198	CrCbGaD
Adinazolam—GABRB3—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000672	0.00105	CbGpPWpGaD
Adinazolam—GABRG3—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.00067	0.00105	CbGpPWpGaD
Adinazolam—GABRA5—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000669	0.00105	CbGpPWpGaD
Adinazolam—GABRA1—SIDS Susceptibility Pathways—SLC6A4—attention deficit hyperactivity disorder	0.000667	0.00105	CbGpPWpGaD
Adinazolam—GABRA1—SIDS Susceptibility Pathways—SNAP25—attention deficit hyperactivity disorder	0.000667	0.00105	CbGpPWpGaD
Adinazolam—GABRA4—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000667	0.00104	CbGpPWpGaD
Adinazolam—GABRA5—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000665	0.00104	CbGpPWpGaD
Adinazolam—GABRG2—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00066	0.00103	CbGpPWpGaD
Adinazolam—GABRB1—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.00066	0.00103	CbGpPWpGaD
Adinazolam—GABRA3—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000657	0.00103	CbGpPWpGaD
Adinazolam—GABRB2—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000656	0.00103	CbGpPWpGaD
Adinazolam—GABRA3—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000653	0.00102	CbGpPWpGaD
Adinazolam—GABRA2—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000646	0.00101	CbGpPWpGaD
Adinazolam—GABRB3—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000641	0.00101	CbGpPWpGaD
Adinazolam—GABRA2—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000641	0.00101	CbGpPWpGaD
Adinazolam—GABRB3—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000637	0.000999	CbGpPWpGaD
Adinazolam—GABRA5—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000637	0.000998	CbGpPWpGaD
Adinazolam—GABRG2—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00063	0.000987	CbGpPWpGaD
Adinazolam—GABRG2—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000626	0.000981	CbGpPWpGaD
Adinazolam—GABRA3—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000626	0.00098	CbGpPWpGaD
Adinazolam—Chlorpromazine—ADRA2A—attention deficit hyperactivity disorder	0.000625	0.0184	CrCbGaD
Adinazolam—GABRA6—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000624	0.000979	CbGpPWpGaD
Adinazolam—GABRG3—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000623	0.000976	CbGpPWpGaD
Adinazolam—GABRA4—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000617	0.000966	CbGpPWpGaD
Adinazolam—GABRG3—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000616	0.000965	CbGpPWpGaD
Adinazolam—GABRA2—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000615	0.000963	CbGpPWpGaD
Adinazolam—GABRB1—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000614	0.000961	CbGpPWpGaD
Adinazolam—GABRG3—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000612	0.000959	CbGpPWpGaD
Adinazolam—GABRB3—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000611	0.000957	CbGpPWpGaD
Adinazolam—GABRB2—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.00061	0.000956	CbGpPWpGaD
Adinazolam—GABRB1—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000607	0.000951	CbGpPWpGaD
Adinazolam—GABRB1—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000603	0.000944	CbGpPWpGaD
Adinazolam—GABRB3—BDNF signaling pathway—BDNF—attention deficit hyperactivity disorder	0.000602	0.000943	CbGpPWpGaD
Adinazolam—GABRR1—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000601	0.000942	CbGpPWpGaD
Adinazolam—GABRG2—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.0006	0.00094	CbGpPWpGaD
Adinazolam—GABRR1—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000597	0.000935	CbGpPWpGaD
Adinazolam—GABRA5—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000592	0.000928	CbGpPWpGaD
Adinazolam—GABRA1—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.000588	0.000922	CbGpPWpGaD
Adinazolam—GABRA3—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000582	0.000912	CbGpPWpGaD
Adinazolam—GABRA6—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000581	0.00091	CbGpPWpGaD
Adinazolam—GABRA1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000577	0.000904	CbGpPWpGaD
Adinazolam—GABRA6—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000574	0.0009	CbGpPWpGaD
Adinazolam—GABRA4—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000573	0.000898	CbGpPWpGaD
Adinazolam—GABRR2—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000573	0.000898	CbGpPWpGaD
Adinazolam—GABRA2—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000572	0.000896	CbGpPWpGaD
Adinazolam—GABRA6—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.00057	0.000893	CbGpPWpGaD
Adinazolam—GABRR2—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000569	0.000892	CbGpPWpGaD
Adinazolam—GABRB3—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000568	0.00089	CbGpPWpGaD
Adinazolam—GABRA4—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000567	0.000888	CbGpPWpGaD
Adinazolam—GABRB2—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000564	0.000884	CbGpPWpGaD
Adinazolam—GABRA4—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000563	0.000882	CbGpPWpGaD
Adinazolam—GABRG2—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000558	0.000874	CbGpPWpGaD
Adinazolam—GABRG3—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000555	0.00087	CbGpPWpGaD
Adinazolam—GABRA1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000551	0.000863	CbGpPWpGaD
Adinazolam—GABRA5—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000548	0.000858	CbGpPWpGaD
Adinazolam—GABRA1—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000547	0.000857	CbGpPWpGaD
Adinazolam—GABRB1—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000547	0.000857	CbGpPWpGaD
Adinazolam—GABRA3—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000538	0.000843	CbGpPWpGaD
Adinazolam—Clomipramine—HTR2A—attention deficit hyperactivity disorder	0.000534	0.0157	CrCbGaD
Adinazolam—Chlorprothixene—HTR2A—attention deficit hyperactivity disorder	0.000532	0.0156	CrCbGaD
Adinazolam—GABRA2—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000529	0.000828	CbGpPWpGaD
Adinazolam—GABRB3—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000525	0.000823	CbGpPWpGaD
Adinazolam—GABRA1—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000524	0.000822	CbGpPWpGaD
Adinazolam—GABRB2—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000524	0.000822	CbGpPWpGaD
Adinazolam—GABRB2—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000519	0.000813	CbGpPWpGaD
Adinazolam—GABRA6—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000517	0.000811	CbGpPWpGaD
Adinazolam—GABRG2—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000516	0.000808	CbGpPWpGaD
Adinazolam—GABRB2—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000515	0.000807	CbGpPWpGaD
Adinazolam—GABRA4—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000511	0.000801	CbGpPWpGaD
Adinazolam—GABRA5—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000509	0.000798	CbGpPWpGaD
Adinazolam—GABRA5—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000504	0.000789	CbGpPWpGaD
Adinazolam—GABRA1—SIDS Susceptibility Pathways—MAOA—attention deficit hyperactivity disorder	0.000502	0.000787	CbGpPWpGaD
Adinazolam—GABRA5—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.0005	0.000784	CbGpPWpGaD
Adinazolam—GABRA3—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.0005	0.000784	CbGpPWpGaD
Adinazolam—GABRA3—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000495	0.000775	CbGpPWpGaD
Adinazolam—GABRA2—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000492	0.00077	CbGpPWpGaD
Adinazolam—GABRA3—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000491	0.00077	CbGpPWpGaD
Adinazolam—GABRB3—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000488	0.000765	CbGpPWpGaD
Adinazolam—GABRA1—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000488	0.000764	CbGpPWpGaD
Adinazolam—GABRA2—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000486	0.000762	CbGpPWpGaD
Adinazolam—GABRA1—SIDS Susceptibility Pathways—BDNF—attention deficit hyperactivity disorder	0.000484	0.000759	CbGpPWpGaD
Adinazolam—GABRB3—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000483	0.000757	CbGpPWpGaD
Adinazolam—GABRA2—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000483	0.000756	CbGpPWpGaD
Adinazolam—GABRB3—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.00048	0.000751	CbGpPWpGaD
Adinazolam—GABRG2—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000479	0.000751	CbGpPWpGaD
Adinazolam—GABRG2—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000474	0.000743	CbGpPWpGaD
Adinazolam—Chlorpromazine—DRD2—attention deficit hyperactivity disorder	0.000474	0.0139	CrCbGaD
Adinazolam—GABRG3—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000472	0.00074	CbGpPWpGaD
Adinazolam—GABRG2—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000471	0.000738	CbGpPWpGaD
Adinazolam—GABRG3—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000469	0.000734	CbGpPWpGaD
Adinazolam—GABRB2—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000467	0.000732	CbGpPWpGaD
Adinazolam—GABRB1—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000465	0.000729	CbGpPWpGaD
Adinazolam—GABRB1—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000462	0.000723	CbGpPWpGaD
Adinazolam—GABRA5—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000454	0.000711	CbGpPWpGaD
Adinazolam—GABRA1—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000451	0.000706	CbGpPWpGaD
Adinazolam—CYP2C19—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000449	0.000704	CbGpPWpGaD
Adinazolam—GABRA3—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000446	0.000699	CbGpPWpGaD
Adinazolam—GABRA6—Neuronal System—COMT—attention deficit hyperactivity disorder	0.00044	0.000689	CbGpPWpGaD
Adinazolam—GABRA2—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000438	0.000686	CbGpPWpGaD
Adinazolam—GABRA6—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000437	0.000685	CbGpPWpGaD
Adinazolam—GABRB3—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000435	0.000682	CbGpPWpGaD
Adinazolam—GABRA4—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000434	0.000681	CbGpPWpGaD
Adinazolam—GABRA4—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000431	0.000676	CbGpPWpGaD
Adinazolam—GABRG2—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000427	0.00067	CbGpPWpGaD
Adinazolam—GABRA1—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000419	0.000657	CbGpPWpGaD
Adinazolam—GABRA1—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000415	0.00065	CbGpPWpGaD
Adinazolam—GABRA1—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000412	0.000645	CbGpPWpGaD
Adinazolam—GABRA1—SIDS Susceptibility Pathways—HTR2A—attention deficit hyperactivity disorder	0.000409	0.000641	CbGpPWpGaD
Adinazolam—GABRB2—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000397	0.000623	CbGpPWpGaD
Adinazolam—GABRB2—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000395	0.000618	CbGpPWpGaD
Adinazolam—GABRA5—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000386	0.000605	CbGpPWpGaD
Adinazolam—GABRA5—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000383	0.000601	CbGpPWpGaD
Adinazolam—GABRR1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.00038	0.000595	CbGpPWpGaD
Adinazolam—GABRA3—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000379	0.000594	CbGpPWpGaD
Adinazolam—GABRA3—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000376	0.00059	CbGpPWpGaD
Adinazolam—GABRA1—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000374	0.000585	CbGpPWpGaD
Adinazolam—GABRA2—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000372	0.000584	CbGpPWpGaD
Adinazolam—GABRB3—Neuronal System—COMT—attention deficit hyperactivity disorder	0.00037	0.00058	CbGpPWpGaD
Adinazolam—GABRA2—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.00037	0.00058	CbGpPWpGaD
Adinazolam—GABRB3—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000367	0.000576	CbGpPWpGaD
Adinazolam—Chlorpromazine—HTR2A—attention deficit hyperactivity disorder	0.000366	0.0108	CrCbGaD
Adinazolam—GABRG2—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000363	0.000569	CbGpPWpGaD
Adinazolam—GABRR2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000362	0.000568	CbGpPWpGaD
Adinazolam—GABRG2—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000361	0.000565	CbGpPWpGaD
Adinazolam—GABRA1—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000318	0.000498	CbGpPWpGaD
Adinazolam—GABRA1—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000315	0.000494	CbGpPWpGaD
Adinazolam—GABRG3—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000298	0.000468	CbGpPWpGaD
Adinazolam—GABRB1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000294	0.000461	CbGpPWpGaD
Adinazolam—GABRA6—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000278	0.000436	CbGpPWpGaD
Adinazolam—GABRA4—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000275	0.00043	CbGpPWpGaD
Adinazolam—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00027	0.000423	CbGpPWpGaD
Adinazolam—GABRB2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000251	0.000394	CbGpPWpGaD
Adinazolam—GABRA5—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000244	0.000382	CbGpPWpGaD
Adinazolam—CYP2C19—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00024	0.000377	CbGpPWpGaD
Adinazolam—GABRA3—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.00024	0.000376	CbGpPWpGaD
Adinazolam—CYP2C19—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000239	0.000374	CbGpPWpGaD
Adinazolam—CYP2C19—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000237	0.000371	CbGpPWpGaD
Adinazolam—GABRA2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000236	0.000369	CbGpPWpGaD
Adinazolam—GABRB3—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000234	0.000367	CbGpPWpGaD
Adinazolam—GABRG2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.00023	0.00036	CbGpPWpGaD
Adinazolam—GABRA1—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	0.000217	0.00034	CbGpPWpGaD
Adinazolam—GABRA1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000201	0.000315	CbGpPWpGaD
Adinazolam—CYP3A4—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000145	0.000226	CbGpPWpGaD
Adinazolam—CYP3A4—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000144	0.000225	CbGpPWpGaD
Adinazolam—CYP3A4—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000143	0.000223	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—ADRA2C—attention deficit hyperactivity disorder	9.83e-05	0.000154	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—TPH2—attention deficit hyperactivity disorder	6.78e-05	0.000106	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—CACNB2—attention deficit hyperactivity disorder	6.78e-05	0.000106	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—DPYD—attention deficit hyperactivity disorder	6.67e-05	0.000105	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—CACNA1C—attention deficit hyperactivity disorder	6.2e-05	9.72e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	5.91e-05	9.26e-05	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—SNAP25—attention deficit hyperactivity disorder	5.42e-05	8.5e-05	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—ADRA2A—attention deficit hyperactivity disorder	5.16e-05	8.09e-05	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—COMT—attention deficit hyperactivity disorder	4.11e-05	6.44e-05	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—MAOA—attention deficit hyperactivity disorder	4.08e-05	6.4e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	4.08e-05	6.39e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	4.08e-05	6.39e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	4.01e-05	6.29e-05	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	3.96e-05	6.2e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	3.73e-05	5.85e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	3.26e-05	5.11e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	3.1e-05	4.87e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	2.47e-05	3.87e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	2.45e-05	3.85e-05	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—EP300—attention deficit hyperactivity disorder	1.76e-05	2.76e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	1.06e-05	1.66e-05	CbGpPWpGaD
